The agency wants Congress to intervene, saying it does not have adequate oversight powers to ensure the safety of the myriad cannabidiol products derived from hemp.
FDA Seeks More Authority to Oversee CBD Products
The New York Times – Business:
This post first appeared in The New York Times – Business. Read the original article.
Written by
in